Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 2403 (LINC02403) is a long intergenic non-coding RNA (lincRNA) gene found in the human genome[1]. LincRNAs are a subclass of long non-coding RNAs transcribed from regions that do not overlap protein-coding loci and are considered to exert regulatory influence on gene expression, often through epigenetic, chromatin, transcriptional, or post-transcriptional mechanisms[1][7][9]. However, the specific molecular function, biological pathways, and disease associations for LINC02403 itself are currently not well defined in the scientific literature[1]. In general, lincRNAs can be involved in a broad array of cellular processes, including regulation of chromatin, transcription, and nuclear architecture, and some have been implicated in human disease, but there is insufficient functional annotation for LINC02403 to establish it as a therapeutic target[1][7][9]. Context and supporting details: - LINC02403 is categorized as a long intergenic non-coding RNA (lincRNA), not a protein-coding gene, and is listed in gene databases such as GeneCards[1]. - lincRNAs in general act in biological functions such as gene regulation and epigenetic modulation, but most lack detailed annotation or established direct roles in signaling pathways or diseases[7][9]. - There is no evidence LINC02403 is a recognized therapeutic target (such as receptor, enzyme, or transporter) or directly targeted by any approved or experimental drugs as of the present database information[1]. - No mechanism of action, drug interaction, biomarker, or specific safety/therapeutic role is documented for LINC02403[1]. If further details on function, disease association, or potential as a target emerge in future research, entries may need to be updated. At present, this lincRNA is primarily of interest in non-coding RNA research, and not as a therapeutic target[1][7][9].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 2403 (LINC02403).